Quadratus Lumborum Block by Paraspinous Sagittal Shift Approach for Hip Surgery

Tthe Anaesthetic Efficacy of Quadratus Lumborum Block by Paraspinous Sagittal Shift Approach for Hip Surgery:a Case Series

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04628923

Enrollment

Registered

2020-11-16

Start date

2020-11-20

Completion date

2020-12-30

Last updated

2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self Efficacy

Brief summary

The quadratus lumborum block (QLB) was first described by Blanco. it is a compartment block procedure during which a local anesthetic is injected into the muscle plane of the quadratus lumborum (QL) muscle under ultrasound guidance Currently, QLB is divided into four types based on the injection point of the local anesthetic: lateral, anterior, posterior, and intramuscular QLB. QLB is widely used for various types of abdominal surgeries (

Detailed description

the investigators will evaluate the anesthetic efficacy of quadratus lumborum block by paraspinous sagittal shift approach for hip surgery by injecting 30 ml of 0. 5% bupivacaine.

Interventions

OTHERQUADRATUS LUMBORUM BLOCK

QUADRATUS LUMBORUM BLOCK BY PARASPINOUS SAGITTAL SHIFT APPROACH

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

30 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

-ASA I and II

Exclusion criteria

* Contraindications for regional blocks (eg. Patient refusal Infection at the injection site, coagulopathy) * Allergic reaction to drugs. * opium addiction, any drug or substance abuse and chronic treatment with opium, non-steroidal anti-inflammatory drugs

Design outcomes

Primary

Measure	Time frame	Description
sensory and motor block level	immediately after the intervention/procedure/surgery	BY PIN PRICK

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026